BALCX
Price
$36.73
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
252.49B
MBERX
Price
$31.39
Change
-$0.07 (-0.22%)
Updated
Aug 6 closing price
Net Assets
441.82M
Interact to see
Advertisement

BALCX vs MBERX

Header iconBALCX vs MBERX Comparison
Open Charts BALCX vs MBERXBanner chart's image
American Funds American Balanced C
Price$36.73
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets252.49B
NYLI Balanced Class R6
Price$31.39
Change-$0.07 (-0.22%)
VolumeN/A
Net Assets441.82M
BALCX vs MBERX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. MBERX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and MBERX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 252B vs. MBERX (442M). MBERX pays higher dividends than BALCX: MBERX (2.30) vs BALCX (1.18). BALCX was incepted earlier than MBERX: BALCX (24 years) vs MBERX (8 years). BALCX (1.31) is less costly to investors than MBERX (0.74). MBERX is a more actively managed with annual turnover of: 230.00 vs. BALCX (44.00). MBERX has a lower initial minimum investment than BALCX: MBERX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 9.98 vs. MBERX (4.52). BALCX return over 5 years is better than : 32.54 vs. MBERX (13.71).
BALCXMBERXBALCX / MBERX
Total Expense Ratio1.310.74177%
Annual Report Gross Expense Ratio1.310.74177%
Fund Existence24 years8 years-
Gain YTD8.1554.717173%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets252B442M57,014%
Annual Yield % from dividends1.182.3051%
Returns for 1 year9.984.52221%
Returns for 3 years28.7216.05179%
Returns for 5 years32.5413.71237%
Returns for 10 years57.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGND142.407.01
+5.18%
Ligand Pharmaceuticals
DBI2.870.02
+0.70%
Designer Brands
BEKE17.52-0.04
-0.23%
KE Holdings
TARA3.11-0.04
-1.27%
Protara Therapeutics
APM1.29-0.11
-7.86%
Aptorum Group Limited